Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

@article{Granger2005AdherenceTC,
  title={Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial},
  author={Bradi B. Granger and Karl Swedberg and Inger Ekman and Christopher B. Granger and for the Charm investigators},
  journal={The Lancet},
  year={2005},
  volume={366},
  pages={2005-2011}
}
BACKGROUND Chronic heart failure (CHF) is an important cause of hospital admission and death. Poor adherence to medication is common in some chronic illnesses and might reduce the population effectiveness of proven treatments. Because little is known about adherence in patients with CHF and about the consequences of non-adherence, we assessed the association between adherence and clinical outcome in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 210 CITATIONS, ESTIMATED 44% COVERAGE

Patient Activation in Acute Decompensated Heart Failure.

VIEW 9 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.

  • European journal of heart failure
  • 2016
VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

A competency framework for clinical pharmacists and heart failure.

  • The International journal of pharmacy practice
  • 2018
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2006
2019

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019